Phase I trial of thalidomide and Interleukin-2 in patients with metastatic renal cell carcinoma

By Olencki Thomas   Malhi Sareena   Mekhail Tarek   Dreicer Robert   Elson Paul   Wood Laura   Bukowski Ronald  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 321-326

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of oral talactoferrin alfa in refractory solid tumors

By Hayes Teresa   Falchook Gerald   Varadhachary Gauri   Smith Dori   Davis Lisa   Dhingra Hari   Hayes Benjamin   Varadhachary Atul  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 233-240

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of vinflunine and pemetrexed in refractory solid tumors

By Sanoff Hanna   Davies Janine   Walko Christine   Buie Larry   Chiu Wing-Keung   Ivanova Anastasia   O’Neil Bert   Stinchcombe Thomas   Keller Kimberly   Dees E.  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 131-136

Springer Publishing Company

Access to resources Recommend Favorite

Phase 1 trial of Anvirzel™ in patients with refractory solid tumors

By Mekhail Tarek   Kaur Hanspreet   Ganapathi Ram   Budd G.   Elson Paul   Bukowski Ronald  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 423-427

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors

By Feldman Darren   Turkula Stefan   Ginsberg Michelle   Ishill Nicole   Patil Sujata   Carousso Maryann   Bosl George   Motzer Robert  

Investigational New Drugs, Vol. 28, Iss. 4, 2010-08 ,pp. : 523-528

Springer Publishing Company

Access to resources Recommend Favorite